Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for Vascular Abnormalities in Rheumatoid Arthritis
NCT01270087Phase 4Completed
- Sponsor
- Skåne University Hospital
- Start
- May 2005
- Primary completion
- Feb 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Skåne University Hospital. Started May 2005; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01270087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270087.